Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species
Jakob E. Brune,Michael Dickenmann,Daniel Sidler,Laura N. Walti,Déla Golshayan,Oriol Manuel,Fadi Haidar,Dionysios Neofytos,Aurelia Schnyder,Katia Boggian,Thomas F. Mueller,Thomas Schachtner,Nina Khanna,Stefan Schaub,Caroline Wehmeier,the Swiss Transplant Cohort Study,Patrizia Amico,John-David Aubert,Adrian Bachofner,Vanessa Banz,Sonja Beckmann,Guido Beldi,Christoph Berger,Ekaterine Berishvili,Annalisa Berzigotti,Pierre-Yves Bochud,Sanda Branca,Heiner Bucher,Anne Cairoli,Emmanuelle Catana,Yves Chalandon,Sabina De Geest,Sophie De Seigneux,Michael Dickenmann,Joëlle Lynn Dreifuss,Michel Duchosal,Thomas Fehr,Sylvie Ferrari-Lacraz,Jaromil Frossard,Christian Garzoni,Déla Golshayan,Nicolas Goossens,Fadi Haidar,Jörg Halter,Dominik Heim,Christoph Hess,Sven Hillinger,Hans Hirsch,Patricia Hirt,Linard Hoessly,Günther Hofbauer,Uyen Huynh-Do,Franz Immer,Michael Koller,Andreas Kremer,Christian Kuhn,Bettina Laesser,Frédéric Lamoth,Roger Lehmann,Alexander Leichtle,Oriol Manuel,Hans-Peter Marti,Michele Martinelli,Valérie McLin,Katell Mellac,Aurélia Merçay,Karin Mettler,Nicolas Müller,Ulrike Müller-Arndt,Beat Müllhaupt,Mirjam Nägeli,Graziano Oldani,Manuel Pascual,Jakob Passweg,Rosemarie Pazeller,Klara Posfay-Barbe,David Reineke,Juliane Rick,Anne Rosselet,Simona Rossi,Rössler,Silvia Rothlin,Frank Ruschitzka,Thomas Schachtner,Stefan Schaub,Alexandra Scherrer,Dominik Schneidawind,Aurelia Schnyder,Macé Schuurmans,Simon Schwab,Thierry Sengstag,Federico Simonetta,Jürg Steiger,Guido Stirniman,Ueli Stürzinger,Christian Van Delden,Jean-Pierre Venetz,Jean Villard,Julien Vionnet,Madeleine Wick,Markus Wilhlem,Patrick Yerly,
DOI: https://doi.org/10.3389/fmed.2024.1329778
IF: 3.9
2024-02-15
Frontiers in Medicine
Abstract:Background Enterobacterales are often responsible for urinary tract infection (UTI) in kidney transplant recipients. Among these, Escherichia coli or Klebsiella species producing extended-spectrum beta-lactamase (ESBL) are emerging. However, there are only scarce data on frequency and impact of ESBL-UTI on transplant outcomes. Methods We investigated frequency and impact of first-year UTI events with ESBL Escherichia coli and/or Klebsiella species in a prospective multicenter cohort consisting of 1,482 kidney transplants performed between 2012 and 2017, focusing only on 389 kidney transplants having at least one UTI with Escherichia coli and/or Klebsiella species . The cohort had a median follow-up of four years. Results In total, 139/825 (17%) first-year UTI events in 69/389 (18%) transplant recipients were caused by ESBL-producing strains. Both UTI phenotypes and proportion among all UTI events over time were not different compared with UTI caused by non-ESBL-producing strains. However, hospitalizations in UTI with ESBL-producing strains were more often observed (39% versus 26%, p = 0.04). Transplant recipients with first-year UTI events with an ESBL-producing strain had more frequently recurrent UTI (33% versus 18%, p = 0.02) but there was no significant difference in one-year kidney function as well as longer-term graft and patient survival between patients with and without ESBL-UTI. Conclusion First-year UTI events with ESBL-producing Escherichia coli and/or Klebsiella species are associated with a higher need for hospitalization but do neither impact allograft function nor allograft and patient survival.
medicine, general & internal